1. Home
  2. CVEO vs NERV Comparison

CVEO vs NERV Comparison

Compare CVEO & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

N/A

Current Price

$33.56

Market Cap

297.0M

ML Signal

N/A

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

N/A

Current Price

$5.26

Market Cap

301.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVEO
NERV
Founded
1977
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.0M
301.6M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
CVEO
NERV
Price
$33.56
$5.26
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$37.00
$10.50
AVG Volume (30 Days)
68.5K
129.4K
Earning Date
05-01-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
$7.72
N/A
Revenue Next Year
$5.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.75
$1.48
52 Week High
$36.50
$12.46

Technical Indicators

Market Signals
Indicator
CVEO
NERV
Relative Strength Index (RSI) 59.75 42.57
Support Level $24.96 $5.02
Resistance Level $34.80 $6.69
Average True Range (ATR) 1.45 0.38
MACD -0.02 -0.04
Stochastic Oscillator 50.92 47.54

Price Performance

Historical Comparison
CVEO
NERV

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: